Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agnieszka Ida

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 10, 2013
FUT11 as a potential biomarker of clear cell renal cell carcinoma progression based on meta-analysis of gene expression dataElżbieta Zodro, Marcin Jaroszewski, Agnieszka Ida, et al.
Wideochirurgia I Inne Techniki Maloinwazyjne = Videosurgery and Other Miniinvasive Techniques|June 23, 2025
Learning curve for laparoscopic radical prostatectomyAnna Barnaś, Tomasz Milecki, Agnieszka Ida, et al.
BMC Cancer|July 15, 2015
Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumorsTomasz Wrzesiński, Malgorzata Szelag, Wojciech A Cieślikowski, et al.
Cancers|June 13, 2019
Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration AssaysJoanna Budna-Tukan, Monika Świerczewska, Martine Mazel, et al.
Journal of Personalized Medicine|April 28, 2023
Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate CancerWojciech A Cieślikowski, Piotr Milecki, Monika Świerczewska, et al.
Cancers|January 16, 2020
Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate CancerWojciech A Cieślikowski, Joanna Budna-Tukan, Monika Świerczewska, et al.
Oncotarget|February 18, 2017
Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNAKatarzyna Kluzek, Malgorzata I Srebniak, Weronika Majer, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 10, 2013
FUT11 as a potential biomarker of clear cell renal cell carcinoma progression based on meta-analysis of gene expression dataElżbieta Zodro, Marcin Jaroszewski, Agnieszka Ida, et al.
Wideochirurgia I Inne Techniki Maloinwazyjne = Videosurgery and Other Miniinvasive Techniques|June 23, 2025
Learning curve for laparoscopic radical prostatectomyAnna Barnaś, Tomasz Milecki, Agnieszka Ida, et al.
BMC Cancer|July 15, 2015
Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumorsTomasz Wrzesiński, Malgorzata Szelag, Wojciech A Cieślikowski, et al.
Cancers|June 13, 2019
Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration AssaysJoanna Budna-Tukan, Monika Świerczewska, Martine Mazel, et al.
Journal of Personalized Medicine|April 28, 2023
Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate CancerWojciech A Cieślikowski, Piotr Milecki, Monika Świerczewska, et al.
Cancers|January 16, 2020
Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate CancerWojciech A Cieślikowski, Joanna Budna-Tukan, Monika Świerczewska, et al.
Oncotarget|February 18, 2017
Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNAKatarzyna Kluzek, Malgorzata I Srebniak, Weronika Majer, et al.
Pageof 1